41 results
8-K
EX-2.1
ODYY
Odyssey Health, Inc.
5 Oct 23
Oragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug Candidate
6:30am
as a result of or arising out of the transactions contemplated by this Agreement.
4.27.2. The Company is not a party to, nor or has any commitment to become … , the Company will not, without the prior written consent of Purchaser:
(a) enter into any Contract or commitment related to the Business, the Purchased
8-K
EX-10.2
ODYY
Odyssey Health, Inc.
18 Aug 23
Entry into a Material Definitive Agreement
5:10pm
, and Lender shall respond with a firm commitment within ten (10) business days of notice.
IN WITNESS WHEREOF, the undersigned has executed this Secured
8-K
s73ri9 6fcvq
4 Nov 22
Odyssey Health Inc. Strengthens Commitment to Odyssey NeuroPharma Through Expansion of Executive Team
4:16pm
8-K
EX-99.1
o7ocp 3j4
4 Nov 22
Odyssey Health Inc. Strengthens Commitment to Odyssey NeuroPharma Through Expansion of Executive Team
4:16pm
424B3
55v0nugcw2619t wk
9 Aug 22
Prospectus supplement
9:26am
8-K
EX-99.1
yz05nnutypra27x zyp
20 Apr 22
Regulation FD Disclosure
5:15pm